SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Roach ES, Gomez MR, Northrup H. Tuberous Sclerosis Complex Consensus Conference: revised clinical diagnostic criteria. J Child Neurol 1998;13: 6248.
  • 2
    Curatolo P, Verdecchia M, Bombardieri R. Tuberous sclerosis complex: a review of neurological aspects. Eur J Paediatr Neurol 2002;6: 1523.
  • 3
    Dabora SL, Jozwiak S, Franz DN. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared to TSC1, disease in multiple organs. Am J Hum Genet 2001;68: 6480.
  • 4
    Jozwiak S, Kwiatkowski D, Kasprzyk-Obara J, et al. Epilepsy and especially infantile spasms are more frequent among patients with TSC2 mutations. J Child Neurol 2001;16: 275.
  • 5
    Jozwiak S, Schwartz RA, Janniger CK, et al. Usefulness of diagnostic criteria of tuberous sclerosis complex in pediatric patients. J Child Neurol 2000;15: 6529.
  • 6
    Webb DW, Fryer AE, Osborne JP. Morbidity associated with tuberous sclerosis: a population study. Dev Med Child Neurol 1996;38: 14655.
  • 7
    Sparagana SP, Delgado MR, Batchelor LL, et al. Seizure remission and antiepileptic drug discontinuation in children with tuberous sclerosis complex. Arch Neurol 2003;60: 12869.
  • 8
    Webb DW, Fryer AE, Osborne JP. On the incidence of fits and mental retardation in tuberous sclerosis. J Med Genet 1991;28: 3957.
  • 9
    Joinson C, O'Callaghan FJ, Osborne JP, et al. Learning disability in an epidemiological sample of individuals with tuberous sclerosis complex. Psychol Med 2003;33: 33544.
  • 10
    O'Callaghan FJ, Harris T, Joinson C, et al. The relation of infantile spasms, tubers and intelligence in tuberous sclerosis complex. Arch Dis Child 2004;89: 5303.
  • 11
    Bolton PF, Park RJ, Higgins NP, et al. Neuroepileptic determinants of autistic spectrum disorder in tuberous sclerosis complex. Brain 2002;125: 124755.
  • 12
    Taylor DC, Neville BGR, Cross JH. Autistic spectrum disorders in childhood epilepsy surgery candidates. Eur J Adolesc Psychiatr 1999;8: 18992.
  • 13
    Mclellan A, Davies S, Heyman I, et al. Psychopathology in children undergoing temporal lobe resection for the treatment of epilepsy—a pre and post-operative assessment. Dev Med Child Neurol 2005;47: 66672.
  • 14
    Hancock E, Osborne JP. Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review. J Child Neurol 1999;14: 714.
  • 15
    Jambaque I, Chiron C, Dumas C, et al. Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients. Epilepsy Res 2000;38: 15160.
  • 16
    Vanhatalo S, Nousianen I, Eriksson K, et al. Visual field constriction in 91 Finnish children treated with vigabatrin. Epilepsia 2002;43: 74856.
  • 17
    Franz DN, Tudor C, Leonard J. Topiramate as therapy for tuberous sclerosis complex-associated seizures. Epielpsia 2000;41: 87.
  • 18
    Bebin EM, Kelly PJ, Gomez MR. Surgical treatment for epilepsy in cerebral tuberous sclerosis. Epilepsia 1993;34: 6517.
  • 19
    Guerreiro M, Andermann F, Andermann E, et al. Surgical treatment of epilepsy in tuberous sclerosis. Neurology 1998;51: 12639.
  • 20
    Koh S, Jayakar P, Resnick T, et al. The localising value of ictal SPECT in children with tuberous sclerosis complex and refractory partial epilepsy. Epileptic Disord 1999;1: 416.
  • 21
    Karenfort M, Kruse B, Freitag H, et al. Epilepsy surgery outcome in children with focal epilepsy due to tuberous sclerosis complex. Neuropadiatrie 2002;33: 25561.
  • 22
    Koh S, Jayakar P, Dunoyer C, et al. Epilepsy surgery in children with tuberous sclerosis complex: presurgical evaluation and outcome. Epilepsia 2000;41: 120613.
  • 23
    Jansen FE, Braun KPJ, Van Nieuwenhuizen O, et al. Diffusion-weighted magnetic resonance imaging and identification of the epileptogenic tuber in patients with tuberous sclerosis. Arch Neurol 2003;60: 15804.
  • 24
    Chugani DC, Chugani HT, Muzik O, et al. Imaging epileptogenic tubers in children with tuberous sclerosis complex using α[11C] methyl-L-tryptophan positron emission computed tomography. Ann Neurol 1998;44: 85866.
  • 25
    Fedi M, Reutens DC, Andermann F, et al. α-[11C]-methyl-L-tryptophan PET identifies the epileptogenic tuber and correlates with interictal spike frequency. Epilepsy Res 2002;52: 20313.
  • 26
    Asano E, Chugani DC, Muzik O, et al. Multimodality imaging for improved detection of epileptogenic foci in tuberous sclerosis complex. Neurology 2000;54: 197684.
  • 27
    Lachhwani DK, Pestana E, Gupta AK, et al. Identification of candidates for surgery for epilepsy due to tuberous sclerosis. Neurology 2005;(in press).
  • 28
    Jarrar RG, Buchhalter JR, Raffel C. Long-term outcome of epilepsy surgery in patients with tuberous sclerosis. Neurology 2004;62: 47981.
  • 29
    Bebin EM, Gomez MR. Prognosis in Sturge-Weber disease: comparison of unihemispheric and bihemispheric involvement. J Child Neurol 1992;3: 1814.
  • 30
    Sujansky E, Conradi S. Outcome of Sturge-Weber syndrome in 52 adults. Am J Med Genet 1995;57: 3545.
  • 31
    Arzimanoglou A, Aicardi J. The epilepsy of Sturge-Weber syndrome: clinical features and treatment in 23 patients. Acta Neurol Scand Suppl 1992;140: 1822.
  • 32
    Maria BL, Neufeld JA, Rosainz LC, et al. Central nervous system structure and function in Sturge Weber Syndrome: evidence of neurologic and radiologica progression. J Child Neurol 1998;13: 60618.
  • 33
    Castroviejo IP, Diaz Gonzalez CD, Munoz-Hiraldo E. Sturge Weber syndrome: a study of 40 patients. Pediatr Neurol 1993;9: 2837.
  • 34
    Benedikt RA, Brown DC, Walker R, et al. Sturge-Weber syndrome: cranial MR imaging with Gd-DTPA. Am J Neurorad 1993;14: 40915.
  • 35
    Jacoby CG, Ruh WTC, Afifi AK, et al. Accelerated myelination in early Sturge-Weber syndrome demonstrated by MR imaging. J Comput Assist Tomogr 1987;11: 22631.
  • 36
    Chiron C, Raynaud C, Tzourio N, et al. Regional cerebral blood flow by SPECT imaging in Sturge-Weber disease: an aid for diagnosis. J Neurol Neurosurg Psychiatry 1989;52: 14029.
  • 37
    Lee JS, Asano E, Muzik O, et al. Sturge Weber syndrome: correlation between clinical course and FDG PET findings. Neurology 2001;57: 18995.
  • 38
    Gurecki P, Holden K, Sahn EE, et al. Developmental neural abnormalities and seizures in epidermal nevus syndrome. Dev Med Child Neurol 1996;38: 71623.
  • 39
    Pavonne L, Curatolo P, Rizzo R, et al. Epidermal nevus syndrome: a neurologic variant with hemimegalancephaly, gyral malformation, mental retardation, seizures and facial hemihypertrophy. Neurology 1991;41: 26671.
  • 40
    Ito M. Studies of melanin XI. Incontinentia pigmenti achromians, a singular case of naevus depigmentosis systematicus bilateralis. Tohoku J Exp Med 1952;55: s57s59.
  • 41
    Yang JH, Sy M, Tsai CH. Destructive encephalopathy in incontinentia pigmenti: a case report. J Dermatol 1995;22: 3403.
  • 42
    Hennel SJ, Ekert PG, Volpe JJ, et al. Insights into the pathogenesis of cerebral lesions in incontinentia pigmenti. Pediatr Neurol 2003;29: 14850.
  • 43
    Pascual-Castroviejo I, Roche MC, Fernandez VM, et al. Incontinentia pigmenti: MR demonstration of brain changes. AJNR Am J Neuroradiol 1994;15: 15217.
  • 44
    Arun D, Gutmann DH. Recent advances in neurofibromatosis 1. Curr Opin Neurol 2004;17: 1015.
  • 45
    Vivarelli R, Grosso S, Calabrese F, et al. Epilepsy in neurofibromatosis 1. J Child Neurol 2003;18: 33842.
  • 46
    Kulkantrakorn K, Geller T. Seizures in neurofibromatosis 1. Pediatr Neurol 1998;19: 34750.
  • 47
    North KN. Clinical aspects of neurofibromatosis 1. Eur J Paediatr Neurol 1998;2: 22331.
  • 48
    Shen MH, Harper PS, Upadhyaya M. Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet 1996;33: 217.
  • 49
    Arun D, Gutmann DH. Recent advances in neurofibromatosis type 1. Curr Opin Neurol 2004;17: 1015.
  • 50
    Hyman SL, Gill DS, Shores EA, et al. Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1. Neurology 2003;60: 113945.
  • 51
    Cardoso MT, De Caevalho TB, Casulari LA, et al. Proteus syndrome and somatic mosaicism of the chromosome 16. Panminerva Med 2003;45: 26771.
  • 52
    Griffiths PD, Welch RJ, Gardner-Medwin D, et al. The radiological features of hemimegalancephaly including three cases with proteus syndrome. Neuropediatrics 1994;25: 1404.
  • 53
    Dietrich RB, Glidden DE, Roth GM, et al. The Proteus syndrome: CNS manifestations. AJNR Am J Neuroradiol 1998;19: 98790.
  • 54
    Mclellan A, Parmeggiani L, Chong WK, et al. The spectrum of hemimegalancephaly—a clinical, neurophysiological and neuroradiological overview. Dev Med Child Neurol 2003;45: 7.